Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Kasama, M

    1. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
      H Imamura, Y Furukawa, H Nakano, M Kasama, Y Hoyano and S Chiba
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 467-472;

  2. Kato, M

    1. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
      Y Kita, Y Hirasawa, S Fukuyama, K Ohkubo, Y Kato, H Takamatsu, M Ohno, S Nishino, M Kato and J Seki
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 421-425;

  3. Kato, Y

    1. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
      Y Kita, Y Hirasawa, S Fukuyama, K Ohkubo, Y Kato, H Takamatsu, M Ohno, S Nishino, M Kato and J Seki
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 421-425;

  4. Kest, B

    1. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.
      J S Mogil, B Kest, B Sadowski and J K Belknap
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 532-544;

  5. Khanapure, S P

    1. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
      W S Powell, J Rokach, S P Khanapure, S Manna, M Hashefi, S Gravel, R J Macleod, J R Falck and R K Bhatt
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 728-736;

  6. Killilea, D W

    1. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
      J Haynes, D W Killilea, P D Peterson and W J Thompson
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 752-757;

  7. Kita, Y

    1. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
      Y Kita, Y Hirasawa, S Fukuyama, K Ohkubo, Y Kato, H Takamatsu, M Ohno, S Nishino, M Kato and J Seki
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 421-425;

  8. Klein, T W

    1. Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation.
      Y Daaka, H Friedman and T W Klein
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 776-783;

  9. Kleven, M S

    1. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
      M S Kleven and W Koek
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 388-397;

  10. Koek, W

    1. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
      M S Kleven and W Koek
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 388-397;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement